BiotechTube
Home/Baymatob Operations/David O’Reilly
DO

David O’Reilly

Chair of the Board

Baymatob Operations

Therapeutic Areas

Maternal HealthObstetrics

Baymatob Operations Pipeline

DrugIndicationPhase
Oli PPHPostpartum Hemorrhage (PPH) Risk PredictionPhase 3

Leadership Team at Baymatob Operations

TC
Tara Croft
CEO
DS
Dr Sarah McDonald
Founder & CTO
SA
Santhi Analytis
Non‑Executive Director
View full Baymatob Operations profile